Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $22.33B | $21.41B | $20.64B | $21.09B | $21.18B | $17.12B | $16.75B | $9.26B |
| Cost of revenue | $19.94B | $19.07B | $18.51B | $18.96B | $19.13B | $15.23B | $14.93B | $8.45B |
| Gross profit | $2.38B | $2.35B | $2.13B | $2.13B | $2.05B | $1.88B | $1.81B | $803.8M |
| Gross margin | 10.7% | 11.0% | 10.3% | 10.1% | 9.7% | 11.0% | 10.8% | 8.7% |
| R&D | $7.1M | $6.9M | $5.1M | $0 | $0 | $4.2M | $0 | $2.2M |
| Operating income | $158.8M | $621.5M | −$699.4M | −$284.6M | $23.5M | $118.5M | $132.1M | $58.9M |
| EBITDA | $501.7M | $647.9M | $255.0M | $180.2M | $182.5M | $169.6M | $357.3M | $218.7M |
| Net income | $48.6M | $392.9M | −$966.9M | −$299.0M | −$59.0M | −$66.1M | $900.0K | −$49.4M |
| Net margin | 0.2% | 1.8% | -4.7% | -1.4% | -0.3% | -0.4% | 0.0% | -0.5% |
| EPS (diluted) | 0.05 | 0.39 | -0.95 | -0.29 | -0.06 | -0.07 | 0.00 | -0.05 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds CAKFY.
No tracked institution reports a position in CAKFY as of their last filing.
No one on the platform has traded CAKFY yet.
| +0.00% |
| $1.7B |
| — |
| DCHPFDechra Pharmaceuticals PLC | $46.90 | -0.21% | $5.3B | — |
| DPHAYDechra Pharmaceuticals PLC | $98.00 | +1.98% | $5.6B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.